Skip to main content
MOVE logo

MOVE · Corvex, Inc. · Webcasts, Transcripts & Audio

Track MOVE — free
$7.44 +0.37 (+5.16%) Q2 2026 earnings call transcript
Market Cap
$195.47M
Shares
27.65M
Volume · Oct 28 35.54K Avg daily vol (3M) 363.86K

Corvex, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Corvex, Inc. (MOVE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-08-14
Corvex, Inc. (MOVE) Q2 2026 Earnings Call Transcript
Positive tone Revenue ramp and contracted annualized revenue Security as differentiator Corvex Token Factory product
Revenue
$3.80M
▲ 3590.3% YoY
Diluted EPS
$-5.12
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-19
Corvex, Inc. (MOVE) Q1 2026 Earnings Call Transcript
Confident tone AI Inference / Token Factory Confidential Computing AI Infrastructure / AI Factory Platform
Revenue
$510,000
▲ 147.6% YoY
Diluted EPS
$-3.13
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-11-14
Corvex, Inc. (MOVE) Q3 2024 Earnings Call Transcript
Confident tone FDA 510(k) clearance for EvieMED Ring Smart ring market opportunity Blood pressure and glucose technology (RF)
Revenue
$50,000
Diluted EPS
$-7.78
Gross margin
-1590.0%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Corvex, Inc. (MOVE) Q2 2024 Earnings Call Transcript
Positive tone FDA 510(k) Clearance for EV Med Ring B2B Commercial Opportunities and Partnerships Evie Ring Direct-to-Consumer Relaunch
Revenue
$23,000
Diluted EPS
$-6.85
Gross margin
-1552.2%
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-15
Corvex, Inc. (MOVE) Q1 2024 Earnings Call Transcript
Positive tone FDA 510(k) clearance for Evie Med pulse oximeter mmWave RF blood pressure and glucose technology Evie Ring relaunch and customer experience improvements
Revenue
$852,000
Diluted EPS
$-11.27
Gross margin
-42.6%
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-04-04
Corvex, Inc. (MOVE) Q4 2023 Earnings Call Transcript
Confident tone B2B opportunities for Evie Med Blood pressure monitoring FDA 510(k) clearance for SpO2/pulse rate
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-15
Corvex, Inc. (MOVE) Q3 2023 Earnings Call Transcript
Diluted EPS
$-19.51
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Corvex, Inc. (MOVE) Q2 2023 Earnings Call Transcript
Diluted EPS
$-18.78
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Corvex, Inc. (MOVE) Q1 2023 Earnings Call Transcript
Diluted EPS
$-20.99
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-20
Corvex, Inc. (MOVE) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Corvex, Inc. (MOVE) Q3 2022 Earnings Call Transcript
Diluted EPS
$-28.72
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-15
Corvex, Inc. (MOVE) Q2 2022 Earnings Call Transcript
Diluted EPS
$-23.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Corvex, Inc. (MOVE) Q1 2022 Earnings Call Transcript
Diluted EPS
$-23.20
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-30
Corvex, Inc. (MOVE) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Corvex, Inc. (MOVE) Q3 2021 Earnings Call Transcript
Diluted EPS
$-17.67
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Corvex, Inc. (MOVE) Q2 2021 Earnings Call
Diluted EPS
$-16.57
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Corvex, Inc. (MOVE) Q1 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–17 of 17 webcasts
Key facts CIK 1734750 CUSIP 62459M305 13F (30d) 2 filings 2 filers Visit website Investor relations